Home > Products > Biosimilars

BioSIM anti-Human CD20/MS4A1 Antibody (Ublituximab Biosimilar), Research Grade

Catalog: SIM0789
Cost advantage to: SIM0091
Product Details Specifications Application References Related Products

Product Details

This non-therapeutic Ublituximab biosimilar shares the same variable regions as the therapeutic antibody, targeting a unique CD20 epitope on B cells to mediate depletion via ADCC. Unlike the glycoengineered therapeutic, it is not afucosylated. Ideal for studying CD20 biology, B cell–mediated diseases, and depletion mechanisms in autoimmunity and cancer.
 

Specifications

Product Name BioSIM anti-Human CD20/MS4A1 Antibody (Ublituximab Biosimilar), Research Grade
Size 1mg/5mg
Isotype /
Target CD20/MS4A1
Other Names LFB-R603, TG-1101, TGTX-1101, CAS: 1174014-05-1
CAS 1174014-05-1
Reactivity Human
Host Species Chimeric
Background This non-therapeutic Ublituximab biosimilar shares the same variable regions as the therapeutic antibody, targeting a unique CD20 epitope on B cells to mediate depletion via ADCC. Unlike the glycoengineered therapeutic, it is not afucosylated. Ideal for studying CD20 biology, B cell–mediated diseases, and depletion mechanisms in autoimmunity and cancer.
Applications ELISA, FACS, Functional assay, Research in vivo
Purification Protein A/G
Storage To ensure appropriate storage, Please avoid repeated freeze thaw cycles. Keep the product at 4°C for short-term needs (1–2 weeks); Store at -20°C for up to 12 months.  For long-term storage, store at -80°C.
Shipping 2-8°C with blue ice
Concentration Lot specific, generally ≥ 5.0 mg/ml
Shelf Life 12 months from the date of receipt if stored as recommended
Formulation PBS, pH 7.4, contains no stabilizers or preservatives
Sterility 0.2 μM filtered
Endotoxin ≤ 1.0 EU/mg
Purity 99%

Application References

Related Products